top of page
Untitled design (33)_edited.jpg

Who we are

c3a9af37d240f54e5064148f2caeea9 1 (4).png
Decided introduction decided missions and values website linkedin instagram dates each mon
Doctor and Patient

Welcome to UroMedTech, a pioneering medical technology company founded in Singapore. At UroMedTech, our success is driven by a dynamic and experienced management team that is passionate about revolutionizing urological healthcare. Our team brings together a diverse range of expertise, combining deep knowledge in the medical technology industry with a strong commitment to improving patient outcomes.

Join us on our journey to transform urological healthcare through innovation and collaboration.

Our Tests

Our Mission

Our Speciality

We envision to drive positive changes in the urological care and make a lasting impact on the lives of patients around the world.

​​

With a shared vision for innovation and a dedication to excellence, our management team guides the strategic direction of the company, fosters collaboration with healthcare professionals and industry partners, and ensures that our solutions meet the highest standards of quality and effectiveness.

We specialise in the Urology field and aim to provide cutting-edge solutions for urological health, improving patient outcomes and advancing medical practices.

We are passionate about driving progress in urological healthcare, delivering top-tier medical devices that set new standards in the industry.

Contact Us

Blk 71 Ayer Rajah Crescent #04-18/19

Singapore 139951

Phone: +65 8919 9394

Email: marketing@uromedtech.com

  • LinkedIn

Please fill in the form if you would like to get in touch with us!

1. Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, et al. Magnetic Resonance Imaging/Ultrasound–Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy. European Urology. 2013 Nov;64(5):713–9.

2. Srinivas Vourganti, Rastinehad AR, Nitin Yerram, Nix JW, Dmitry Volkin, Hoang A, et al. Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies. 2012 Dec 1;188(6):2152–7.

3. Power J, Ryan J, Hutchinson B, Brady D, Hannan M, Kieran O'Malley, et al. Change from transrectal to transperineal ultrasound-guided prostate biopsy under local anaesthetic eliminates sepsis as a complication. The Journal of hospital infection/Journal of hospital infection. 2022 Jul 1;125:44–7.

 

 

Copyright© UroMedTech Pte. Ltd. All rights reserved. UroMedtech Reserves the right to modify the design, specifications and features shown herein, without prior notice or obligation.

bottom of page